Showing results (11-20 of 1,072) with videos related to

Sort By:
Pageof 108
Expert Opinion on Biological Therapy|December 22, 2017
Canakinumab for secondary prevention of atherosclerotic diseaseDavide Capodanno, Dominick J Angiolillo
The American Journal of Cardiology|March 12, 2021
Aspirin for Primary Prevention of Cardiovascular Disease in the 21<sup>st</sup> Century: A Review of the EvidenceDominick J Angiolillo, Davide Capodanno
Circulation|October 13, 2016
Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes MellitusDavide Capodanno, Dominick J Angiolillo
Nature Reviews. Cardiology|August 5, 2016
Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular diseaseDavide Capodanno, Mark Alberts, Dominick J Angiolillo
Therapeutic Advances in Cardiovascular Disease|December 10, 2019
Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stentingSergio Buccheri, Dominick J Angiolillo, Davide Capodanno
Expert Review of Cardiovascular Therapy|July 15, 2020
An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitusDario Calderone, Davide Capodanno, Dominick J Angiolillo
Expert Opinion on Pharmacotherapy|July 24, 2024
The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic strokeClaudio Laudani, Davide Capodanno, Dominick J Angiolillo
Expert Opinion on Drug Metabolism & Toxicology|October 18, 2023
Evaluating the pharmacokinetic and pharmacodynamic impact of different modes of ticagrelor administrationMarco Spagnolo, Dominick J Angiolillo, Davide Capodanno
Expert Review of Cardiovascular Therapy|February 9, 2010
Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12 receptor antagonistDavide Capodanno, Kodlipet Dharmashankar, Dominick J Angiolillo
Pageof 108